Menu
Logo XIII World Congress of Cardiology - 1998 - Rio de Janeiro - Brazil


1. ARRHYTHMIAS (clinical), general

    1.1. Electrocardiography
    1.2. Ambulatory ECG (Holter)
    1.3. Programmed stimulation
    1.4. Signal averaged ECG
    1.5. Antiarrhythmic drugs (clinical)
    1.6. Non-pharmacological therapy, general
    1.7. Catheter ablation
    1.8. Sudden death
    1.9. Wolff-Parkinson-White syndrome
    1.10. Heart rate & QT variability baroreceptors
    1.11. Defibrillation, general
    1.12. Automatic Implantable. Cardioverter/Defribillator
    1.13. Supraventricular arrhythmias
    1.14. Ventricular arrhythmias
    1.15. Conduction system

2. ARRHYTHMIAS (mechanisms), general

    2.1. Disturbances in impulse formation
    2.2. Disturbances in impulse conduction
    2.3. Mapping (experimental & clinical)
    2.4. Antirrhythmic drugs, experimental studies
    2.5. Autonomic nervous system, experimental studies
    2.6. Arrhythmias in ischaemia & infarction (experimental)
    2.7. Arrhythmias in Hypertrophy & heart failure (experimental)

3. AUTONOMIC NERVOUS SYSTEM, general

    3.1. Adrenoceptors
    3.2. Cholinergic drugs/receptors

4. BLOOD VESSELS (basic research), general

    4.1. Endothelium
    4.2. Vascular smooth muscle
    4.3. Flow in intact vessels
    4.4. Local control mechanisms
    4.5. Angiogenesis
    4.6. Microvessels
    4.7. Collaterals

5. CARDIAC CELLULAR BIOLOGY (basic research), general

    5.1. Structure
    5.2. Isolated myocytes
    5.3. Metabolism
    5.4. Ischaemia
    5.5. Myocardial protection
    5.6. Myocardial Hypertrophy
    5.7. Molecular biology
    5.8. Cardiomyopathy, myocarditis
    5.9. Myocardial Membranes
    5.10. Excitation/contraction coupling
    5.11. Myocardial proteins
    5.12. Contractile function

6. GENETIC ENGINEERING

7. CARDIAC PACING, general

    7.1. Pacing, bifocal
    7.2. Antitachycardia
    7.3. Pacemacker technology

8. CARDIOVASCULAR DISEASE IN PREGNANCY

9. CARDIOVASCULAR DISEASE IN ELDERLY

10. CARDIOVASULAR NURSING

11. CARDIOVASCULAR PATHOPHYSIOLOGY

12. CARDIOVASCULAR PATHOPHYSIOLOGY,general

    12.1. Neural control
    12.2. Humoral control
    12.3. Atrial natriuretic factor

13. CARDIOVASCULAR SURGERY

    13.1. Coronary artery disease
    13.2. Congenital heart disease
    13.3. Valvular disease
    13.4. Antitachycardia, surgery
    13.5. Intensive care
    13.6. Cardiac Transplantation
    13.7. Heart, artificial
    13.8. Myocardial protection, clinical
    13.9. Associated complications
    13.10. Support devices

14. CELLULAR ELECTROPHYSIOLOGY (basic research)

15. COMPUTERS IN CARDIOLOGY

    15.1. Image processing
    15.2. Diagnostic ECG
    15.3. Ambulatory ECG
    15.4. ECG mapping
    15.5. Medical decision making
    15.6. Databases
    15.7. Signal processing techniques
    15.8. Knowledge systems

16. CONGESTIVE HEART FAILURE, general

    16.1. Metabolism
    16.2. Experimental
    16.3. Neural mechanisms
    16.4. Peripheral circulation
    16.5. Myocardial function
    16.6. Hypertrophy
    16.7. Diagnosis
    16.8. Prognosis
    16.9. Treatment

17. CORONARY CIRCULATION

    17.1. Coronary artery disease, general
    17.2. Coronary circulation, experimental studies
    17.3. Angina pectoris, stable or unstable
    17.4. Coronary vasospasm
    17.5. Myocardial ischaemia
    17.6. Coronary flow, techniques/results
    17.7. Coronary flow reserve
    17.8. Quantitative coronary angiography
    17.9. Angiocradiograhpy
    17.10. Kawasakis disease

18. DEVELOPMENTAL ANATOMY & PATHOLOGY

19. DRUG THERAPY

    19.1. Pharmacology, general
    19.2. Pharmacokinetics
    19.3. Drug interactions
    19.4. Adrenergic receptor agonists & antagonists
    19.5. Adrenergic receptor agonists & antagonists
    19.6. Antithypertensive agents, general
    19.7. ACE inhibitors
    19.8. Calcium channel blockers, general
    19.9. Calcium channel blockers, angina pectoris
    19.10. Digitalis
    19.11. Diuretics, general
    19.12. Drugs, genetic techniques
    19.13. Inotropic agents
    19.14. Nitrates
    19.15. Cardiac receptors
    19.16. Lipid-lowering drugs
    19.17. Anti-ischaemic drugs

20. ECHOCARDIOGRAPHY, general

    20.1. Doppler
    20.2. Colour Doppler
    20.3. Stress echo
    20.4. Transoesophageal (TEE)
    20.5. Contrast echo
    20.6. Intravascular echo

21. EPIDEMIOLOGY & PREVENTION, general

    21.1. Arteriosclerosis
    21.2. Lipids
    21.3. Coronary heart disease, MI
    21.4. Interventions
    21.5. Health education
    21.6. Prevention, cardiovascular disease
    21.7. Prognosis, general
    21.8. Cardiomyopathy
    21.9. Hypertension
    21.10. Congestive Heart Failure

22. CARDIOVASCULAR DISEASE IN WOMEN

23. EXERCISES TESTING, general

    23.1. in coronary artery disease
    23.2. in valvular & congenital heart disease
    23.3. in congestive heart-failure

24. GROWN UP CONGENITAL HEART DISEASE,general

25. HYPERTENSION, general

    25.1. Experimental
    25.2. ACE-system
    25.3. Atrial natriuretic peptide (factor)
    25.4. Autonomic nervous system
    25.5. Blood pressure mechanisms
    25.6. Diuretics, hypertension
    25.7. Hypertension, the heart in
    25.8. Endothelial factors
    25.9. Hypertension, secondary
    25.10. Haemodynamics
    25.11. Hormones, electrolytes, membranes
    25.12. Treatment
    25.13. Ambulatory blood pressure
    25.14. Renin-angiotensin-aldosterone system
    25.15. Children and adolescents

26. INTERVENTIONAL CARDIOLOGY, general

    26.1. Coronary balloon angioplasty, general
    26.2. Angioplasty, restenosis
    26.3. Coronary atherectomy (excisional, rotational, extracting)
    26.4. Coronary laser angioplasty
    26.5. Coronary stenting
    26.6. Coronary angioplasty, new devices
    26.7. Angioscopy, coronary intravascular ultrasound
    26.8. LV assistance during coronary angioplasty

27. MICROCIRCULATION

28. MYOCARDIAL FUNCTION, general

    28.1. Systolic function
    28.2. Diastolic function
    28.3. Myocardial contraction

29. MYOCARDIAL INFARCTION, general


  • 29.1. Mechanisms & physiopathology
    29.2. Acute phase
    29.3. Post infarction period
    29.4. Prognosis
    29.5. Thrombolysis
    29.6. Coronary angioplasty in MI
    29.7. CCU

30. MYOCARDIAL & PERICARDIAL DISORDERS, general

    30.1. Toxic
    30.2. Cardiomyopaty, general
    30.3. Dilated cardiomyopathy
    30.4. Hypertrophic cardiomyopathy
    30.5. Pericardial diseas
    30.6. Vasculitis
    30.7. Tumours y
    30.8. Myocarditis
    30.9. Biopsy
    30.10. Prognosis
    30.11. Virus
    30.12. Immunological
    30.13. Infiltrative
    30.14. Endomyocardial disease

31. NUCLEAR CARDIOLOGY & MRI, general

    31.1. Scintigraphy
    31.2. Positron emission tomography (PET)
    31.3. Magnetic resonance imaging/spectroscopy

32. PAEDIATRIC CARDIOLOGY, general

    32.1. Diagnosis
    32.2. Interventions
    32.3. Treatment

33. PATHOGENESIS OF ATHEROSCLEROSIS (basic research), general

    33.1. Models
    33.2. Lipids
    33.3. Free radicals
    33.4. Molecular biology
    33.5. Cell proliferation & growth factors
    33.6. Progression/Regression of atherosclerosis

34. PERIPHERAL CIRCULATION, general

    34.1. Angiography
    34.2. Laser
    34.3. PTA
    34.4. Atherectomy, peripheral
    34.5. Venous disease
    34.6. Arteritis
    34.7. Vasospasm
    34.8. Aneurysm
    34.9. Carotid Artery
    34.10. Takayasu disease

35. PULMONARY CIRCULATION, general

    35.1. Cor pulmonale
    35.2. Hypertension, pulmonary
    35.3. Pulmonary disease
    35.4. Pulmonary embolism

36. REHABILITATION, general

37. SOCIO-ECONOMIC ASPECTS OF CARDIOLOGY, general

    37.1. Management
    37.2. Economics
    37.3. Audit
    37.4. Legal aspects
    37.5. Ethical aspects
    37.6. Certification
    37.7. Organisation of education
    37.8. Iatrogenic disorders

38. STROKE

39. THROMBOSIS & PLATELETS, general

    39.1. Anticoagulant drugs & therapy
    39.2. Antiplatelet agents & therapy
    39.3. Antithrombotic agents & therapy
    39.4. Thrombolytic agents & therapy
    39.5. Thrombo-embolic diseases
    39.6. Platelets & thrombosis

40. VALVULAR HEART DISEASE, general

    40.1. Aortic valve disease
    40.2. Mitral valve disease
    40.3. Mitral valve prolapse
    40.4. Pulmonary valve disease
    40.5. Tricuspid valve disease
    40.6. Complications
    40.7. Endocarditis
    40.8. Valvular allo-prostheses
    40.9. Bioprostheses
    40.10. Valvuplasty

41. RHEUMATIC FEVER, general

42. CHAGASS DISEASE, general

Menu